Novartis Cuts 20% of Drug-Research Projects After Review

Novartis Cuts 20% of Drug-Research Projects After Review

Submitted by admin on October 30, 2018 - 12:12pm
Source: 
Bloomberg
News Tags: 
Novartis
R&D
drug development
Headline: 
Novartis Cuts 20% of Drug-Research Projects After Review
snippet: 

Novartis AG has dropped about a fifth of its research projects as the drugmaker narrows its focus on the most cutting-edge medicines.

Do Not Allow Advertisers to Use My Personal information